csirt@kutim:~/threat-intel/cve/CVE-2026-32262

Katalog CVE

CVSS 4.3 · Medium EPSS 0,37%

Kerentanan Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') pada craftcms craft cms. Skor CVSS 3.1 4.3 (Medium) menurut NVD.

Deskripsi (NVD)

Craft CMS is a content management system (CMS). From version 4.0.0-RC1 to before version 4.17.5 and from version 5.0.0-RC1 to before version 5.9.11, the AssetsController->replaceFile() method has a targetFilename body parameter that is used unsanitized in a deleteFile() call before Assets::prepareAssetName() is applied on save. This allows an authenticated user with replaceFiles permission to delete arbitrary files within the same filesystem root by injecting ../ path traversal sequences into the filename. This could allow an authenticated user with replaceFiles permission on one volume to delete files in other folders/volumes that share the same filesystem root. This only affects local filesystems. This issue has been patched in versions 4.17.5 and 5.9.11.

Rincian

Terbit di NVD
16 Maret 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
4.3 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
EPSS (30 hari)
0,37% peluang dieksploitasi; lebih tinggi dari 28,4% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
craftcms craft cms Versi 4.0.0.1 hingga sebelum 4.17.5
craftcms craft cms Versi 5.0.1 hingga sebelum 5.9.11
craftcms craft cms Versi 4.0.0
craftcms craft cms Versi 4.0.0 rc1
craftcms craft cms Versi 4.0.0 rc2
craftcms craft cms Versi 4.0.0 rc3
craftcms craft cms Versi 5.0.0
craftcms craft cms Versi 5.0.0 rc1

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.